Trials / Completed
CompletedNCT02321865
Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Nobelpharma · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to check the dose control method of NPC-02 and the holding effect for the target serum zinc concentration in patients with zinc deficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NPC-02 |
Timeline
- Start date
- 2015-01-21
- Primary completion
- 2015-11-01
- Completion
- 2015-11-24
- First posted
- 2014-12-22
- Last updated
- 2019-04-16
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02321865. Inclusion in this directory is not an endorsement.